Literature DB >> 21402562

Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.

Yutaka Inaba, Remi Ozawa, Tomoyuki Imagawa, Masaaki Mori, Yoshinori Hara, Takako Miyamae, Chie Aoki, Tomoyuki Saito, Shumpei Yokota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21402562     DOI： 10.1136/ard.2010.145359

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.

Authors:  Paola Cipriani; Piero Ruscitti; Francesco Carubbi; Ilenia Pantano; Vasiliki Liakouli; Onorina Berardicurti; Roberto Giacomelli
Journal:  Clin Rheumatol       Date:  2013-09-05       Impact factor: 2.980

Review 2.  Update on the pathogenesis and treatment of systemic idiopathic arthritis.

Authors:  Keith A Sikora; Alexei A Grom
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

Review 3.  Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis.

Authors:  James E Frampton
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 4.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan Dewitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

Review 5.  Advances and challenges in imaging in juvenile idiopathic arthritis.

Authors:  Silvia Magni-Manzoni; Clara Malattia; Stefano Lanni; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

6.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

7.  Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.

Authors:  Shumpei Yokota; Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-12       Impact factor: 5.346

Review 8.  Tocilizumab in pediatric rheumatology: the clinical experience.

Authors:  Reut Gurion; Nora G Singer
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

Review 9.  The Effect of Anti-rheumatic Drugs on the Skeleton.

Authors:  B Hauser; H Raterman; S H Ralston; W F Lems
Journal:  Calcif Tissue Int       Date:  2022-06-30       Impact factor: 4.000

10.  Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.

Authors:  Clara Malattia; Nicolino Ruperto; Silvia Pederzoli; Elena Palmisani; Angela Pistorio; Carine Wouters; Pavla Dolezalova; Berit Flato; Stella Garay; Gabriella Giancane; Chris Wells; Wendy Douglass; Hermine I Brunner; Fabrizio De Benedetti; Angelo Ravelli
Journal:  Arthritis Res Ther       Date:  2020-09-10       Impact factor: 5.156
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.